Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage.

International journal of oncology

Volumn 26, Issue 3, 2005, Pages 649-659

  Menendez, Javier A ^a   Mehmi, Inderjit ^a   Lupu, Ruth ^a  

^a EVANSTON NORTHWESTERN HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CDKN1A PROTEIN, HUMAN; CELL CYCLE PROTEIN; CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; EPIDERMAL GROWTH FACTOR RECEPTOR 2; NEU DIFFERENTIATION FACTOR;

ARTICLE; BREAST TUMOR; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; DNA DAMAGE; DNA REPAIR; DRUG RESISTANCE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PATHOLOGY; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELL SURVIVAL; CISPLATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; DNA REPAIR; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEUREGULIN-1; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

MLCS; MLOWN;

EID: 20344402091     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.26.3.649     Document Type: Article

References (0)